ID: ALA4168880

Max Phase: Preclinical

Molecular Formula: C161H247N47O40S6

Molecular Weight: 3673.44

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  C#CC[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H]3CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(N)=O)[C@@H](C)CC)NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC(=O)[C@H](CCCC)NC(=O)[C@H](CCc4ccccc4)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N3)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC2=O

Standard InChI:  InChI=1S/C161H247N47O40S6/c1-11-14-38-98-139(229)197-114(71-91-74-179-97-40-21-19-37-94(91)97)150(240)208-129(87(10)210)158(248)206-122-82-254-250-78-118-152(242)189-102(44-25-29-63-165)140(230)196-111(68-84(6)7)146(236)198-113(70-90-73-178-96-39-20-18-36-93(90)96)148(238)204-119(153(243)190-104(46-31-65-176-160(171)172)138(228)184-99(41-22-26-60-162)137(227)193-109(56-59-126(216)217)144(234)207-128(130(168)220)85(8)13-3)79-251-249-77-117(201-131(221)86(9)181-134(224)103(45-30-64-175-159(169)170)186-135(225)101(43-24-28-62-164)188-151(241)116(76-209)200-149(239)115(72-127(218)219)199-156(122)246)157(247)205-121(154(244)191-106(55-58-125(214)215)133(223)180-75-124(213)182-110(67-83(4)5)145(235)187-105(141(231)202-118)47-32-66-177-161(173)174)81-253-252-80-120(203-147(237)112(195-132(222)95(166)33-12-2)69-89-48-51-92(211)52-49-89)155(245)194-108(54-57-123(167)212)143(233)185-100(42-23-27-61-163)136(226)192-107(142(232)183-98)53-50-88-34-16-15-17-35-88/h2,15-21,34-37,39-40,48-49,51-52,73-74,83-87,95,98-122,128-129,178-179,209-211H,11,13-14,22-33,38,41-47,50,53-72,75-82,162-166H2,1,3-10H3,(H2,167,212)(H2,168,220)(H,180,223)(H,181,224)(H,182,213)(H,183,232)(H,184,228)(H,185,233)(H,186,225)(H,187,235)(H,188,241)(H,189,242)(H,190,243)(H,191,244)(H,192,226)(H,193,227)(H,194,245)(H,195,222)(H,196,230)(H,197,229)(H,198,236)(H,199,246)(H,200,239)(H,201,221)(H,202,231)(H,203,237)(H,204,238)(H,205,247)(H,206,248)(H,207,234)(H,208,240)(H,214,215)(H,216,217)(H,218,219)(H4,169,170,175)(H4,171,172,176)(H4,173,174,177)/t85-,86-,87+,95-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,128-,129-/m0/s1

Standard InChI Key:  IVVQUXZDEFTOMS-FXNYBQPYSA-N

Associated Targets(Human)

Sodium channel protein type IV alpha subunit 583 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Sodium channel protein type IX alpha subunit 8393 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 3673.44Molecular Weight (Monoisotopic): 3670.7063AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Wu B, Murray JK, Andrews KL, Sham K, Long J, Aral J, Ligutti J, Amagasu S, Liu D, Zou A, Min X, Wang Z, Ilch CP, Kornecook TJ, Lin MJ, Be X, Miranda LP, Moyer BD, Biswas K..  (2018)  Discovery of Tarantula Venom-Derived NaV1.7-Inhibitory JzTx-V Peptide 5-Br-Trp24 Analogue AM-6120 with Systemic Block of Histamine-Induced Pruritis.,  61  (21): [PMID:30346167] [10.1021/acs.jmedchem.8b00736]

Source